234 related articles for article (PubMed ID: 21822948)
1. Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations.
Dompmartin A; Blaizot X; Théron J; Hammer F; Chene Y; Labbé D; Barrellier MT; Gaillard C; Leroyer R; Chedru V; Ollivier C; Vikkula M; Boon LM
Eur Radiol; 2011 Dec; 21(12):2647-56. PubMed ID: 21822948
[TBL] [Abstract][Full Text] [Related]
2. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.
Jin Y; Lin X; Li W; Hu X; Ma G; Wang W
J Vasc Surg; 2008 Jun; 47(6):1292-9. PubMed ID: 18387776
[TBL] [Abstract][Full Text] [Related]
3. Ethanol-Gel Sclerotherapy of Venous Malformations: Effectiveness and Safety.
Teusch VI; Wohlgemuth WA; Hammer S; Piehler AP; Müller-Wille R; Goessmann H; Uller W
AJR Am J Roentgenol; 2017 Dec; 209(6):1390-1395. PubMed ID: 28929808
[TBL] [Abstract][Full Text] [Related]
4. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
[TBL] [Abstract][Full Text] [Related]
5. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
Kishi K; Morita N; Terada T; Sato M
Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
[TBL] [Abstract][Full Text] [Related]
6. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
[TBL] [Abstract][Full Text] [Related]
7. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
Li L; Feng J; Zeng XQ; Li YH
J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
[TBL] [Abstract][Full Text] [Related]
8. Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents.
Horbach SE; Lokhorst MM; Saeed P; de Goüyon Matignon de Pontouraude CM; Rothová A; van der Horst CM
J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):295-304. PubMed ID: 26723834
[TBL] [Abstract][Full Text] [Related]
9. Sclerotherapy of peripheral venous malformations: a new technique to prevent serious complications.
Ierardi AM; Mangini M; Vaghi M; Cazzulani A; Carrafiello G; Mattassi R
Vasc Endovascular Surg; 2010 May; 44(4):282-8. PubMed ID: 20403950
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
Spence J; Krings T; TerBrugge KG; Agid R
Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
[TBL] [Abstract][Full Text] [Related]
11. Ethanol sclerotherapy of head and neck venous malformations.
Orlando JL; Caldas JG; Campos HG; Nishinari K; Krutman M; Wolosker N
Einstein (Sao Paulo); 2014 Apr; 12(2):181-6. PubMed ID: 25003923
[TBL] [Abstract][Full Text] [Related]
12. Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results.
Lee IH; Kim KH; Jeon P; Byun HS; Kim HJ; Kim ST; Kim YW; Kim DI; Choi JY
Korean J Radiol; 2009; 10(3):269-76. PubMed ID: 19412515
[TBL] [Abstract][Full Text] [Related]
13. Venous Malformations Sclerotherapy: Outcomes, Patient Satisfaction and Predictors of Treatment Success.
Khaitovich B; Kalderon E; Komisar O; Eifer M; Raskin D; Rimon U
Cardiovasc Intervent Radiol; 2019 Dec; 42(12):1695-1701. PubMed ID: 31538233
[TBL] [Abstract][Full Text] [Related]
14. Treatment of venous malformations: first experience with a new sclerosing agent--a multicenter study.
Schumacher M; Dupuy P; Bartoli JM; Ernemann U; Herbreteau D; Ghienne C; Guibaud L; Loose DA; Mattassi R; Petit P; Rössler JK; Stillo F; Weber J
Eur J Radiol; 2011 Dec; 80(3):e366-72. PubMed ID: 21458186
[TBL] [Abstract][Full Text] [Related]
15. Current concepts in diagnosis and treatment of venous malformations.
Judith N; Ulrike E; Siegmar R; Matthias N; Jürgen H
J Craniomaxillofac Surg; 2014 Oct; 42(7):1300-4. PubMed ID: 24969765
[TBL] [Abstract][Full Text] [Related]
16. Staged endovascular and surgical treatment of slow-flow vulvar venous malformations.
Nassiri N; O TM; Rosen RJ; Moritz J; Waner M
Am J Obstet Gynecol; 2013 May; 208(5):366.e1-6. PubMed ID: 23395642
[TBL] [Abstract][Full Text] [Related]
17. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures.
Barranco-Pons R; Burrows PE; Landrigan-Ossar M; Trenor CC; Alomari AI
AJR Am J Roentgenol; 2012 Sep; 199(3):691-4. PubMed ID: 22915413
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
Markovic JN; Nag U; Shortell CK
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312
[TBL] [Abstract][Full Text] [Related]
19. Treatment of venous malformations--comparison to lymphatic malformations.
Schumacher M; Ernemann U; Berlis A; Weber J
Lymphology; 2008 Sep; 41(3):139-46. PubMed ID: 19013882
[TBL] [Abstract][Full Text] [Related]
20. Safety and effectiveness of percutaneous sclerotherapy for venous disorders of the labia majora in patients with vascular malformations.
Brill R; Deistung A; Gussew A; Goldann C; Stangl F; Uller W; Rosendahl J; Wildgruber M; Wohlgemuth WA
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1083-1089. PubMed ID: 32199800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
